PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.48%
Revenue growth above 1.5x TOST's 2.26%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
6.10%
Gross profit growth 1.25-1.5x TOST's 4.64%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
-679.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-679.76%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-679.04%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-600.00%
Negative EPS growth while TOST is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-600.00%
Negative diluted EPS growth while TOST is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
12.45%
Share count expansion well above TOST's 0.94%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
10.94%
Diluted share count expanding well above TOST's 0.94%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-17.07%
Negative OCF growth while TOST is at 72.46%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-28.39%
Negative FCF growth while TOST is at 63.75%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
38.90%
10Y revenue/share CAGR under 50% of TOST's 182.00%. Michael Burry would suspect a lasting competitive disadvantage.
38.90%
5Y revenue/share CAGR under 50% of TOST's 182.00%. Michael Burry would suspect a significant competitive gap or product weakness.
38.90%
3Y revenue/share CAGR under 50% of TOST's 182.00%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-20.85%
Negative 10Y OCF/share CAGR while TOST stands at 55.53%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-20.85%
Negative 5Y OCF/share CAGR while TOST is at 55.53%. Joel Greenblatt would question the firm’s operational model or cost structure.
-20.85%
Negative 3Y OCF/share CAGR while TOST stands at 55.53%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-485.96%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-485.96%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-485.96%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
255.68%
10Y equity/share CAGR at 75-90% of TOST's 307.35%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
255.68%
5Y equity/share CAGR at 75-90% of TOST's 307.35%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
255.68%
3Y equity/share CAGR at 75-90% of TOST's 307.35%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
37.98%
Our AR growth while TOST is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
48.23%
Inventory growth well above TOST's 15.79%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
86.77%
Asset growth above 1.5x TOST's 1.15%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
239.76%
Positive BV/share change while TOST is negative. John Neff sees a clear edge over a competitor losing equity.
-2.72%
We’re deleveraging while TOST stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
325.97%
R&D growth drastically higher vs. TOST's 6.76%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
155.50%
SG&A growth well above TOST's 9.88%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.